Porcine CYP2A19, CYP2E1 and CYP1A2 forms are responsible for skatole biotransformation in the reconstituted system

被引:0
作者
Matal, Jaroslav [1 ]
Matuskova, Zuzana [1 ]
Tunkova, Alena [1 ]
Anzenbacherova, Eva [2 ]
Anzenbacher, Pavel [1 ]
机构
[1] Palacky Univ, Fac Med & Dent, Dept Pharmacol, Olomouc 77515, Czech Republic
[2] Palacky Univ, Fac Med & Dent, Dept Med Chem & Biochem, Olomouc 77515, Czech Republic
关键词
PP; skatole; boar taint; cytochromes P450; CYP; CYTOCHROME-P450; 2A6; LIVER-MICROSOMES; 3-METHYLINDOLE; PIG; METABOLISM; EXPRESSION; PURIFICATION; INDUCTION; P450;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES: To study the contribution of individual purified porcine CYP1A2, 2E1 and 2A19 enzymes to the biotransformation of skatole. METHODS: Individual porcine and human enzymes (CYP1A2,2E1 or 2A6/19) were used to study their potential involvement in skatole metabolism. Furthermore, the inhibition experiments using specific inhibitors of CYP1A2, 2E1 or 2A6/19, were performed. For determination of skatole biotransformation by individual CYP forms in reconstituted systems, HPLC method with UV detection was used. RESULTS: The data presented in this paper show that porcine and human CYPs are responsible for the formation of indole-3-carbinol and 3-methyloxindole. Whereas in pig CYP2A19 and CYP1A2 seem to be the most important for metabolism of skatole, in man CYPIA2 and CYP2E1 forms are mainly responsible for the production of the metabolites mentioned above. CONCLUSIONS: The porcine and human CYP1A2,2E1, 2A6/19 forms contribute to formation of 3-methyloxindole and indole-3-carbinol.
引用
收藏
页码:36 / 40
页数:5
相关论文
共 50 条
  • [41] Induction of CYP1A1 and CYP2E1 in rat liver by histamine: binding and kinetic studies
    Víctor M. Dávila-Borja
    Javier A. Belmont
    J. Javier Espinosa
    Rafael Moreno-Sánchez
    Arnulfo Albores
    Regina D. Montero
    Archives of Toxicology, 2007, 81 : 697 - 709
  • [42] The involvement of CYP1A2 in biodegradation of dioxins in pigs
    Swigonska, Sylwia
    Molcan, Tomasz
    Nynca, Anna
    Ciereszko, Renata E.
    PLOS ONE, 2022, 17 (05):
  • [43] CYP2A13 metabolizes the substrates of human CYP1A2, phenacetin, and theophylline
    Fukami, Tatsuki
    Nakajima, Miki
    Sakai, Haruko
    Katoh, Miki
    Yokoi, Tsuyoshi
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (03) : 335 - 339
  • [44] The effects of Puerarin on CYP2D6 and CYP1A2 activities In vivo
    Jiao Zheng
    Bin Chen
    Bing Jiang
    Ling Zeng
    Zhi-Rong Tang
    Lan Fan
    Hong-Hao Zhou
    Archives of Pharmacal Research, 2010, 33 : 243 - 246
  • [45] Toward a systems approach to cytochrome P450 ensemble: interactions of CYP2E1 with other P450 species and their impact on CYP1A2
    Davydova, Nadezhda Y.
    Dangi, Bikash
    Maldonado, Marc A.
    Vavilov, Nikita E.
    Zgoda, Victor G.
    Davydov, Dmitri R.
    BIOCHEMICAL JOURNAL, 2019, 476 : 3661 - 3685
  • [46] Genetic polymorphism in the 5′-flanking region of human CYP1A2 gene:: Effect on the CYP1A2 inducibility in humans
    Nakajima, M
    Yokoi, T
    Mizutani, M
    Kinoshita, M
    Funayama, M
    Kamataki, T
    JOURNAL OF BIOCHEMISTRY, 1999, 125 (04) : 803 - 808
  • [47] Pharmacogenetics of ecstasy: CYP1A2, CYP2C19, and CYP2B6 polymorphisms moderate pharmacokinetics of MDMA in healthy subjects
    Vizeli, Patrick
    Schmid, Yasmin
    Prestin, Katharina
    zu Schwabedissen, Henriette E. Meyer
    Liechti, Matthias E.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 (03) : 232 - 238
  • [48] Effects of notoginsenoside R1 on CYP1A2, CYP2C11, CYP2D1, and CYP3A1/2 activities in rats by cocktail probe drugs
    Yin, Shuo
    Cheng, Yanwen
    Li, Tingting
    Dong, Mei
    Zhao, Haifeng
    Liu, Gaofeng
    PHARMACEUTICAL BIOLOGY, 2016, 54 (02) : 231 - 236
  • [49] Inhibition of CYP3A4 and CYP1A2 by Aegle marmelos and its constituents
    Manda, Vamshi K.
    Avula, Bharathi
    Chittiboyina, Amar G.
    Khan, Ikhlas A.
    Walker, Larry A.
    Khan, Shabana I.
    XENOBIOTICA, 2016, 46 (02) : 117 - 125
  • [50] The Effect of Flavonoid Aglycones on the CYP1A2, CYP2A6, CYP2C8 and CYP2D6 Enzymes Activity
    Bojic, Mirza
    Kondza, Martin
    Rimac, Hrvoje
    Benkovic, Goran
    Males, Zeljan
    MOLECULES, 2019, 24 (17):